Similarly to irisin, adipsin is able to reduce β-cell death (Section 3.1 [205]), and therefore the reduction in its levels that occurs in T2D patients [112,113] may contribute to β-cell loss. This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.